Federico Ambrogi

7.6k total citations · 1 hit paper
167 papers, 4.8k citations indexed

About

Federico Ambrogi is a scholar working on Molecular Biology, Oncology and Surgery. According to data from OpenAlex, Federico Ambrogi has authored 167 papers receiving a total of 4.8k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Molecular Biology, 32 papers in Oncology and 29 papers in Surgery. Recurrent topics in Federico Ambrogi's work include Gene expression and cancer classification (15 papers), Cancer Cells and Metastasis (12 papers) and Statistical Methods and Inference (12 papers). Federico Ambrogi is often cited by papers focused on Gene expression and cancer classification (15 papers), Cancer Cells and Metastasis (12 papers) and Statistical Methods and Inference (12 papers). Federico Ambrogi collaborates with scholars based in Italy, United States and United Kingdom. Federico Ambrogi's co-authors include Elia Biganzoli, Douglas L. Packer, Andrea Natale, Wyn Davies, Shih‐Ann Chen, Riccardo Cappato, Yoshito Iesaka, Hugh Calkins, Jonathan M. Kalman and Allan C. Skanes and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and PLoS ONE.

In The Last Decade

Federico Ambrogi

155 papers receiving 4.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Updated Worldwide Survey on the Methods, Efficacy, and Safety of Catheter Ablation for Human Atrial Fibrillation

2009 1.9k citations Federico Ambrogi, Elia Biganzoli et al. profile →

Peers

Countries citing papers authored by Federico Ambrogi

Since Specialization

Citations

This map shows the geographic impact of Federico Ambrogi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Federico Ambrogi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Federico Ambrogi more than expected).

Fields of papers citing papers by Federico Ambrogi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Federico Ambrogi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Federico Ambrogi. The network helps show where Federico Ambrogi may publish in the future.

Co-authorship network of co-authors of Federico Ambrogi

This figure shows the co-authorship network connecting the top 25 collaborators of Federico Ambrogi. A scholar is included among the top collaborators of Federico Ambrogi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Federico Ambrogi. Federico Ambrogi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Prognostic role of myocardial storage, hypertrophy, and inflammation/fibrosis in Fabry cardiomyopathy: a new predictive score including T1 values 2025 ·European Heart Journal - Quality of Care and Clinical Outcomes ·Antonia Camporeale, (unknown), Maurizio Pieroni, Federico Pieruzzi, Paola Lusardi, (unknown), Laura Econimo, Alessandro P. Burlina, Renzo Mignani, (unknown), Valentina Milani, Federico Ambrogi, Lara Tondi, (unknown), Andrea Attanasio, (unknown), Kelvin Chow, Pietro Spagnolo, Gianpaolo Carrafiello, Massimo Lombardi	0
2	Robust Regression as a Sensible Alternative to the Weighted Ordinary Least Squares Regression in case of Heteroskedasticity. A Tutorial 2024 ·SHILAP Revista de lepidopterología ·Annalisa Orenti, Anna Zolin, Ettore Marubini, Paolo Antonelli, Federico Ambrogi, Bruno Mario Cesana	0
3	Assessing the Association between Biomarkers and COVID-19 Mortality Using the Joint Modelling Approach 2024 ·Life ·Matteo Di Maso, Serena Delbue, Maurizio Sampietro, Monica Ferraroni, (unknown), Maria Dolci, Federico Ambrogi, Pasquale Ferrante	2
4	Swallowing Characteristics in Patients with Multiple System Atrophy Analyzed Using FEES Examination 2023 ·Dysphagia ·Francesco Mozzanica, Nicole Pizzorni, (unknown), Daniela Ginocchio, Anna Colombo, Gabriele Mora, Federico Ambrogi, Tobias Warnecke, Antonio Schindler	4
5	Human cytomegalovirus‐related gastrointestinal disease after kidney transplantation: A systematic review 2023 ·Clinical Transplantation ·(unknown), (unknown), Samuele Iesari, (unknown), Andrea Costantino, Serena Delbue, (unknown), A. Guarneri, Federico Ambrogi, Roberto Cacciola, Mariano Ferraresso, Evaldo Favi	1
6	Sample size and predictive performance of machine learning methods with survival data: A simulation study 2023 ·Statistics in Medicine ·Gabriele Infante, Rosalba Miceli, Federico Ambrogi	11
7	Statistical analysis of high-dimensional biomedical data: a gentle introduction to analytical goals, common approaches and challenges 2023 ·BMC Medicine ·Jörg Rahnenführer, Riccardo De Bin, Axel Benner, Federico Ambrogi, Lara Lusa, Anne‐Laure Boulesteix, Eugenia Migliavacca, Harald Binder, Stefan Michiels, Willi Sauerbrei, Lisa M. McShane, (unknown)	38
8	Magnesium alginate versus proton pump inhibitors for the treatment of laryngopharyngeal reflux: a non-inferiority randomized controlled trial 2022 ·European Archives of Oto-Rhino-Laryngology ·Nicole Pizzorni, Federico Ambrogi, (unknown), (unknown), Carlo Robotti, Jérôme R. Lechien, Antonio Schindler	12
9	Organ Donation after Damage Control Strategy in Trauma Patients: Experience from First Level Trauma Center in Italy 2022 ·Life ·Michele Altomare, (unknown), Stefano Piero Bernardo Cioffi, (unknown), (unknown), Andrea Spota, Roberto Bini, Federico Ambrogi, (unknown), Arturo Chieregato, Osvaldo Chiara, Stefania Cimbanassi	2
10	Lack of ApoA-I in ApoEKO Mice Causes Skin Xanthomas, Worsening of Inflammation, and Increased Coronary Atherosclerosis in the Absence of Hyperlipidemia 2022 ·Arteriosclerosis Thrombosis and Vascular Biology ·Marco Busnelli, Stefano Manzini, (unknown), (unknown), Fabrizia Bonacina, Matteo Chiara, Francesca Arnaboldi, Elena Donetti, Federico Ambrogi, Roberto Oleari, Antonella Lettieri, David S. Horner, Eugenio Scanziani, Giuseppe Danilo Norata, Giulia Chiesa	11
11	Towards an improved pain assessment in castrated horses using facial expressions (HGS) and circulating miRNAs 2021 ·Veterinary Record ·Emanuela Dalla Costa, Francesca Dai, Cristina Lecchi, Federico Ambrogi, Dirk Lebelt, Diana Stucke, Giuliano Ravasio, Fabrizio Ceciliani, Michela Minero	7
12	Prevalence and factors associated with urinary incontinence in females with cystic fibrosis: An Italian single‐center cross‐sectional analysis 2021 ·Pediatric Pulmonology ·(unknown), Simone Gambazza, (unknown), Federico Ambrogi, (unknown), (unknown), Valeria Daccò, (unknown), Carla Colombo	1
13	Advanced Glycation End Products (AGE) and Soluble Forms of AGE Receptor: Emerging Role as Mortality Risk Factors in CKD 2020 ·Biomedicines ·Elena Dozio, Simone Vettoretti, Lara Caldiroli, Silvia Nerini‐Molteni, Lorenza Tacchini, Federico Ambrogi, Piergiorgio Messa, Massimiliano Marco Corsi Romanelli	26
14	Association of supratotal resection with progression-free survival, malignant transformation, and overall survival in lower-grade gliomas 2020 ·Neuro-Oncology ·Marco Rossi, Lorenzo Gay, Federico Ambrogi, Marco Conti Nibali, Tommaso Sciortino, Guglielmo Puglisi, Antonella Leonetti, (unknown), Manuela Caroli, Susanna Cordera, Matteo Simonelli, Federico Pessina, Piera Navarria, Andrea Pace, Riccardo Soffietti, Roberta Rudà, Marco Riva, Lorenzo Bello	79
15	Exercise capacity and ventilation inhomogeneity in cystic fibrosis: A cross‐sectional study 2020 ·Pediatric Pulmonology ·Simone Gambazza, (unknown), (unknown), Federico Ambrogi, (unknown), (unknown), Carla Colombo	4
16	Exercise-induced mitral regurgitation and right ventricle to pulmonary circulation uncoupling across the heart failure phenotypes 2020 ·American Journal of Physiology-Heart and Circulatory Physiology ·Francesco Bandera, (unknown), Marianna Fontana, Sara Boveri, (unknown), Eleonora Alfonzetti, Federico Ambrogi, Marco Guazzi	10
17	Time Length of Negativization and Cycle Threshold Values in 182 Healthcare Workers with Covid-19 in Milan, Italy: An Observational Cohort Study 2020 ·International Journal of Environmental Research and Public Health ·Lisa Cariani, Béatrice Silvia Orena, Federico Ambrogi, Simone Gambazza, (unknown), (unknown), (unknown), (unknown), (unknown), Sara Uceda Renteria, (unknown), (unknown), Ferruccio Ceriotti, G. Lunghi	31
18	Circulating Irisin and esRAGE as Early Biomarkers of Decline of Metabolic Health 2020 ·Journal of Clinical Medicine ·Elena Dozio, Elena Vianello, Clementina Sitzia, Federico Ambrogi, (unknown), (unknown), (unknown), (unknown), Lorenza Tacchini, Massimiliano Marco Corsi Romanelli	13
19	Relationship between swallowing-related quality of life and fiberoptic endoscopic evaluation of swallowing in patients who underwent open partial horizontal laryngectomy 2018 ·European Archives of Oto-Rhino-Laryngology ·Nicole Pizzorni, Antonio Schindler, Marco Fantini, Andy Bertolin, Giuseppe Rizzotto, Federico Ambrogi, Giovanni Succo, Erika Crosetti	5
20	Cell Polarity, Epithelial-Mesenchymal Transition, and Cell-Fate Decision Gene Expression in Ductal Carcinoma In Situ 2012 ·International Journal of Surgical Oncology ·Danila Coradini, Patrizia Boracchi, Federico Ambrogi, Elia Biganzoli, Saro Oriana	6

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact